[
  {
    "ts": null,
    "headline": "Aflac Incorporated (AFL) Presents at UBS Financial Services Conference 2026 Transcript",
    "summary": "Aflac Incorporated (AFL) UBS Financial Services Conference 2026 February 11, 2026 9:40 AM ESTCompany ParticipantsVirgil Miller - PresidentDavid Young - Vice...",
    "url": "https://finnhub.io/api/news?id=9f6c47e5ed3b3c4d13e52fb037ca06d29eef6d4d13033d59541c60e0f93056f8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770812069,
      "headline": "Aflac Incorporated (AFL) Presents at UBS Financial Services Conference 2026 Transcript",
      "id": 139045845,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "AFL",
      "source": "SeekingAlpha",
      "summary": "Aflac Incorporated (AFL) UBS Financial Services Conference 2026 February 11, 2026 9:40 AM ESTCompany ParticipantsVirgil Miller - PresidentDavid Young - Vice...",
      "url": "https://finnhub.io/api/news?id=9f6c47e5ed3b3c4d13e52fb037ca06d29eef6d4d13033d59541c60e0f93056f8"
    }
  },
  {
    "ts": null,
    "headline": "5 Insightful Analyst Questions From Aflac’s Q4 Earnings Call",
    "summary": "Aflac’s fourth quarter saw a positive market response despite missing Wall Street’s revenue and non-GAAP profit expectations, with management attributing performance to product launches and shifting sales dynamics across Japan and the U.S. The Japan business delivered a notable 15.7% sales increase driven by new cancer and medical products, while the U.S. segment benefitted from persistent premium growth and disciplined underwriting. CEO Daniel Amos highlighted that strong persistency and sales",
    "url": "https://finnhub.io/api/news?id=388076616dcdfa663774cb5568c622832d1bb87eb95cacf8bdbee1622b3b9674",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770788328,
      "headline": "5 Insightful Analyst Questions From Aflac’s Q4 Earnings Call",
      "id": 139042534,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AFL",
      "source": "Yahoo",
      "summary": "Aflac’s fourth quarter saw a positive market response despite missing Wall Street’s revenue and non-GAAP profit expectations, with management attributing performance to product launches and shifting sales dynamics across Japan and the U.S. The Japan business delivered a notable 15.7% sales increase driven by new cancer and medical products, while the U.S. segment benefitted from persistent premium growth and disciplined underwriting. CEO Daniel Amos highlighted that strong persistency and sales",
      "url": "https://finnhub.io/api/news?id=388076616dcdfa663774cb5568c622832d1bb87eb95cacf8bdbee1622b3b9674"
    }
  }
]